EDITORIAL MATERIAL
Editorial
More details
Hide details
1
Zakład Zaburzeń Afektywnych, Katedra Psychiatrii, Collegium Medicum UJ
2
Katedra Psychoterapii UJ Collegium Medicum
3
Zakład Psychoterapii SU w Krakowie
Submission date: 2015-04-13
Acceptance date: 2015-04-13
Publication date: 2015-04-30
Corresponding author
Jerzy A. Sobański
Katedra Psychoterapii UJ Collegium Medicum, Lenartowicza 14, 31-138 Kraków, Polska
Psychiatr Pol 2015;49(2):211-212
KEYWORDS
TOPICS
ABSTRACT
Dear Readers
We are happy and proud to announce that we managed to achieve intention announced in the last issue: for the first time in PubMed there is a possibility of direct and free access to the full texts published in Polish Psychiatry (Polish and English language versions are available)!!! For the issue 6/2014 they have been downloaded by Medline users already 500 times. Owing to this, papers by Polish scientists-psychiatrists are more readily available to colleagues from around the world interested in them, and Polish Psychiatry actually becomes journal of international scope. We hope that it will result in a marked improvement in the bibliometric indicators (which, however, is unrealistic to expect in the current or next year) in the following years.
Spring issue of Polish Psychiatry touches several important problems. We pay attention to the texts on addiction – behavioural (Internet addiction) and alcohol. Two papers by prof. M. Wojnar’s team summarize the issues related to the coexistence of alcohol dependence with other psychiatric disorders. The issue of dual diagnosis has already appeared in our magazine (for example [1]). This is an extremely difficult problem, and patients are a real challenge, both therapeutic and diagnostic. They often require a comprehensive approach: pharmacotherapy of comorbid mental illness, psychoeducation, addiction treatment programmes. For these patients the maintenance of abstinence is particularly difficult, especially in a situation of exacerbation of psychopathological symptoms. An important direction is searching for additional pharmacotherapeutic
methods which help to reduce the degree of alcohol abuse and the resulting damage. These include: acamprosate, drugs which are opioid receptor antagonists [2], and in the current issue the authors from the University of Cagliari focused on baclofen. (...)